Literature DB >> 1233239

Effect of diazoxide on left ventricular performance in hypertension.

P Fiegel, P Limbourg, H Just, K F Lang.   

Abstract

The effect of diazoxide on left ventricular performance during rest and isometric exercise (handgrip) was examined in 16 unselected hypertensive patients, 6 of whom had been pretreated with the beta-adrenergic blocking agent pindolol. Diazoxide regularly and promptly produced a fall in left ventricle systolic and end diastolic pressures, and an increase in heart rate and left ventricular dp/dtmax. Haemodynamic changes were maximal 2 minutes after injection of the drug and decreased little over the next 8 minutes. After beta-adrenergic blockade, diazoxide caused a more pronounced reduction in left ventricular systolic pressure and a less marked fall in end-diastolic pressure, whilst the diazoxide-induced rise in heart rate was partially and the increase of dp/dtmax was completly inhibited. The increase in systolic pressure during isometric exercise was not influenced by diazoxide, but the positive inotropic reaction was augmented. The findings appear to show that cardiac stimulation by diazoxide is due to a reflex mechanism transmitted by baroreceptors, and that improvement of cardiac performance is mainly due to a reduction of left ventricular after-load.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1233239     DOI: 10.1007/bf00562311

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  THE SYSTEMIC AND CORONARY HEMODYNAMIC EFFECTS OF DIAZOXIDE.

Authors:  G G ROWE; T R LEICHT; W C BOAKE; J C KYLE; C W CRUMPTON
Journal:  Am Heart J       Date:  1963-11       Impact factor: 4.749

2.  AN ADRENERGIC MECHANISM FOR HYPERGLYCEMIA INDUCED BY DIAZOXIDE.

Authors:  M STAQUET; R YABO; J VIKTORA; F WOLFF
Journal:  Metabolism       Date:  1965-09       Impact factor: 8.694

3.  Pharmacology of diazoxide, an antihypertensive, nondiuretic benzothiadiazine.

Authors:  A A RUBIN; F E ROTH; R M TAYLOR; H ROSENKILDE
Journal:  J Pharmacol Exp Ther       Date:  1962-06       Impact factor: 4.030

4.  Phentolamine for vasodilator treatment of severe heart-failure.

Authors:  P A Majid; B Sharma; S H Taylor
Journal:  Lancet       Date:  1971-10-02       Impact factor: 79.321

5.  [Contraction and output capacity of the heart with coronary disease during beta adrenolysis using LB 46 (visken)].

Authors:  P Limbourg; H Just
Journal:  Z Kreislaufforsch       Date:  1972-09

6.  Phentolamine: use in pulmonary edema. Preliminary report.

Authors:  L Gould; M Zahir; M Shariff; M Giuliani
Journal:  Jpn Heart J       Date:  1970-03

7.  Management of severe hypertension with intravenous injections of diazoxide.

Authors:  W E Miller; R W Gifford; D C Humphrey; D G Vidt
Journal:  Am J Cardiol       Date:  1969-12       Impact factor: 2.778

8.  [Inotropic influence of vagal stimulation on canine ventricle in situ].

Authors:  G Kissling; R Jacob; U Peiper; E Bauereisen
Journal:  Pflugers Arch       Date:  1969-06-24       Impact factor: 3.657

9.  Role of peripheral resistance in the control of cardiac output.

Authors:  G L Evans; H Smulyan; R H Eich
Journal:  Am J Cardiol       Date:  1967-08       Impact factor: 2.778

10.  Hypertensive vascular disease. The long term effect of rapid repeated reductions of arterial pressure with diazoxide.

Authors:  F A Finnerty; M Davidov; N Kakaviatos
Journal:  Am J Cardiol       Date:  1967-03       Impact factor: 2.778

View more
  1 in total

1.  Use of a simulation model to study the acute haemodynamic effects of diazoxide in man.

Authors:  A O Brubakk; J Bathen
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.